High blood pressure is associated with an increased risk of heart attack and stroke. A new study in the Journal of Clinical Investigation now shows that antagonists of a receptor known as EP1 reduce hypertension in mice and rats. The authors therefore suggest that targeting the PGE2 receptor EP1 might be a viable approach to treating hypertension.
Full Codex Feeds
General Feed